Evaluation of efficacy, safety and tolerability of interferon beta 1b in patients of Chinese origin with multiple sclerosis

被引：0
|
作者：
Lv, C. [1 ]
Zhang, X. H. [2 ]
Cui, L. Y. [3 ]
Xu, X. H. [4 ]
Radue, E. W. [5 ]
Wang, L. R. [6 ]
Beckmann, K. [7 ]
Lampe, J. [8 ]
Pohl, C. [8 ]
Stemper, B. [8 ]
Sandbrink, R. [8 ]
机构：
[1] Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China
[3] Beijing Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China
[4] Minist Publ Hlth, Beijing Hosp, Beijing, Peoples R China
[5] Kantonsspital Basel, Basel, Switzerland
[6] Bayer Healthcare China Co Ltd, Med & Sci Affairs Dept, Shanghai Branch, Shanghai, Peoples R China
[7] Bayer Schering Pharma AG, Bayer Healthcare, Global Clin Dev Clin Stat, Berlin, Germany
[8] Bayer Schering Pharma AG, Bayer Healthcare, Global Clin Dev Specialized Therapeut TA Neurol O, Berlin, Germany
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2009年 / 285卷
关键词：
D O I：
10.1016/S0022-510X(09)70461-7
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S115 / S115
页数：1
相关论文
共 50 条
  • [1] Evaluation of Efficacy, Safety and Tolerability of Interferon Beta-1b in Patients of Chinese Origin with Multiple Sclerosis
    Lu, C.
    Zhang, X.
    Cui, L.
    Xu, X.
    Radue, E.
    Wang, L.
    Beckmann, K.
    Lampe, J.
    Pohl, C.
    Stemper, B.
    Sandbrink, R.
    [J]. MULTIPLE SCLEROSIS, 2010, 16 (02): : 272 - 272
  • [2] Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis
    Pulicken, M
    Bash, CN
    Costello, K
    Said, A
    Cuffari, C
    Wilterdink, JL
    Rogg, JM
    Mills, P
    Calabresi, PA
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2005, 11 (02) : 169 - 174
  • [3] SWABIMS:: SWiss Atorvastatin and Interferon-Beta 1b trial in multiple sclerosis:: efficacy, safety and tolerability of atorvastatin® 40 mg in patients with relapsing-remitting multiple sclerosis treated with interferon-beta-1b
    Kamm, C.
    Greeve, I.
    Mugglin, A.
    Buhler, R.
    Lienert, C.
    von Bredow, F.
    Schroth, G.
    Mattle, H.
    [J]. MULTIPLE SCLEROSIS, 2006, 12 : S199 - S199
  • [4] Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis
    Banwell, B
    Reder, AT
    Krupp, L
    Tenembaum, S
    Eraksoy, M
    Alexey, B
    Pohl, D
    Freedman, M
    Schelensky, L
    Antonijevic, I
    [J]. NEUROLOGY, 2006, 66 (04) : 472 - 476
  • [5] Optimization of the safety and efficacy of interferon β1b and azathioprine combination therapy in multiple sclerosis
    Calabresi, PA
    Bash, CN
    Costello, K
    Cuffari, C
    Wilterdink, JL
    Rogg, J
    Mills, P
    Syed, A
    [J]. NEUROLOGY, 2004, 62 (07) : A491 - A491
  • [6] Response to beta interferon 1b among Saudi patients with multiple sclerosis
    Kargwell, H
    Yaqub, BA
    Al-Deeb, SM
    [J]. SAUDI MEDICAL JOURNAL, 2003, 24 (01) : 44 - 48
  • [7] Short-term and long-term safety and tolerability of interferon β-1b in multiple sclerosis
    Reder, Anthony T.
    Oger, Joel F.
    Kappos, Ludwing
    O'Connor, Paul
    Rametta, Mark
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (03) : 294 - 302
  • [8] Safety and tolerability of the combination of interferon beta-1a and oral cyclophosphamide for patients with multiple sclerosis
    Kaufman, M
    Norton, J
    Sonnenfeld, G
    [J]. NEUROLOGY, 2001, 56 (08) : A354 - A354
  • [9] Human herpesvirus 6 and effectiveness of interferon beta 1b in multiple sclerosis patients
    Garcia-Montojo, M.
    De Las Heras, V.
    Dominguez-Mozo, M.
    Bartolome, M.
    Garcia-Martinez, M. A.
    Arroyo, R.
    Alvarez-Lafuente, R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (08) : 1027 - 1035
  • [10] The effect of interferon beta 1B on bone mineral density in multiple sclerosis patients
    Varoglu, Asuman Orhan
    Varoglu, Erhan
    Bayraktar, Rezzan
    Aygul, Recep
    Ulvi, Hizir
    Yildirim, Kadir
    [J]. JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2010, 23 (01) : 25 - 29
12345